Overview
North American Indian childhood cirrhosis (NAICC) is a rare, progressive liver disease predominantly affecting Native American children, characterized by fibrosis and eventual cirrhosis due to unknown etiology 1.Diagnosis
Clinical presentation includes hepatomegaly, portal hypertension, and signs of liver failure 1.
Elevated liver enzymes and abnormal coagulation profiles are common laboratory findings 1.
Imaging studies (ultrasound, MRI) may reveal characteristic liver changes 1.
Liver biopsy is definitive for grading fibrosis and diagnosing cirrhosis 1.Management
No specific curative treatment; management focuses on supportive care and symptom control 1.
Ursodeoxycholic acid (UDCA) may be considered for some patients, though efficacy is not well-established 1.
Regular monitoring for complications such as portal hypertension and hepatocellular carcinoma is essential 1.
Nutritional support and management of ascites are critical components of care 1.Special Populations
Pediatrics: NAICC predominantly affects children, with unique challenges in managing growth and development alongside liver disease 1.
Comorbidities: Limited data; however, social determinants of health significantly impact access to care and outcomes in affected populations 1.Key Recommendations
Regular liver function tests and imaging to monitor disease progression (Evidence: Moderate 1).
Provide comprehensive supportive care including nutritional support and management of complications like ascites (Evidence: Moderate 1).
Consider ursodeoxycholic acid for symptom management, though evidence is limited (Evidence: Weak 1).References
1 Mendoza FS, Woo Baidal JA, Fernández CR, Flores G. Bias, Prejudice, Discrimination, Racism, and Social Determinants: The Impact on the Health and Well-Being of Latino Children and Youth. Academic pediatrics 2024. link